We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Iconic Labs Plc | LSE:ICON | London | Ordinary Share | GB00BRBJ3P08 | ORD GBP0.0001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Health & Allied Services,nec | 0 | 4.77M | 0.5697 | 0.09 | 418.58k |
From Jun 2023 to Jun 2024
TIDMICON
RNS Number : 0919Q
Iconic Labs PLC
13 October 2023
13 October 2023
Iconic Labs PLC
("Iconic" or the "Company")
Announcement of the Completion of CVA
Iconic Labs PLC (LSE: ICON) is pleased to announce that the Creditors Voluntary Arrangement ("CVA") has been completed and the relevant documents have been filed at and accepted by Companies House.
Brad Taylor, Chief Executive Officer of Iconic Labs, commented:
"The successful completion of the CVA marks an important step towards Iconic Labs' financial stability. Now that the CVA is discharged, Iconic Labs has removed historic debts and is well positioned to progress with growth opportunities and focus on its strategic goals.
"We look forward to updating shareholders and the market on our further activity in due course."
- Ends -
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
Iconic Labs Tel: +44 (0) 7462 156238 Brad Taylor, Chief Executive ir@iconiclabs.co.uk Officer Novum Securities Limited Tel: +44 (0) 20 7399 9400 David Coffman / Daniel Harris Yellow Jersey PR Tel: +44 (0) 20 3004 9512 Sarah Hollins iconic@yellowjerseypr.com Annabelle Wills Bessie Elliot
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ARINKNBNKBDDKKD
(END) Dow Jones Newswires
October 13, 2023 06:32 ET (10:32 GMT)
1 Year Iconic Labs Chart |
1 Month Iconic Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
